Galecto Stock Soars: Strengthens Blood Cancer Pipeline With Damora Therapeutics Deal, Secures Fresh Funding To 2029
What's Going On With Nano-Cap Galecto Stock On Tuesday?
Galecto shares drop 65% as biotech halts development of lung-disease treatment
Galecto to discontinue development of lung disease treatment